header image

About Octapharma

Octapharma’s core business is the development, production and sale of effective medicines derived from human proteins in the following areas:

  • Immunotherapy
  • Haematology
  • Critical Care

Octapharma is an independent, Swiss-based company founded in 1983 by Mr. Wolfgang Marguerre.

 

The Group has since grown to include state-of-the-art production plants in Austria, France, Germany, Sweden and Mexico, 45 plasma donation centres in the US and Europe as well as 37 subsidiaries and representative offices. With over 4,000 employees, Octapharma currently supplies product to over 80 countries.

 

Octapharma continues to grow and invest heavily in the future. Profits are mainly channelled into R&D and further production improvements and expansion.

 

 

Octapharma Australia

Octapharma Australia Pty Ltd is a wholly owned subsidiary of the Octapharma Group.

 

Octapharma began operating in Australia in 2004, suppling both intravenous human normal immunoglobulin (octagam® 5% and octagam® 10%) and subcutaneous human normal immunoglobulin (gammanorm®).

 

For further information on the current supply of Octapharma products in Australia,  please contact us.

 

 

 

The ongoing journey

Each representing strategic areas